• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下调 Yes 相关蛋白 1 的表达可降低胰腺癌细胞的增殖和克隆形成能力。

Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.

机构信息

Clinical Translational Division, Translational Genomics Research Institute, Scottsdale, Arizona, United States of America.

出版信息

PLoS One. 2012;7(3):e32783. doi: 10.1371/journal.pone.0032783. Epub 2012 Mar 1.

DOI:10.1371/journal.pone.0032783
PMID:22396793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3291657/
Abstract

BACKGROUND

The Hippo pathway regulates organ size by inhibiting cell proliferation and promoting cell apoptosis upon its activation. The Yes Associated Protein 1 (YAP1) is a nuclear effector of the Hippo pathway that promotes cell growth as a transcription co-activator. In human cancer, the YAP1 gene was reported as amplified and over-expressed in several tumor types.

METHODS

Immunohistochemical staining of YAP1 protein was used to assess the expression of YAP1 in pancreatic tumor tissues. siRNA oligonucleotides were used to knockdown the expression of YAP1 and their effects on pancreatic cancer cells were investigated using cell proliferation, apoptosis, and anchorage-independent growth assays. The Wilcoxon signed-rank, Pearson correlation coefficient, Kendall's Tau, Spearman's Rho, and an independent two-sample t (two-tailed) test were used to determine the statistical significance of the data.

RESULTS

Immunohistochemistry studies in pancreatic tumor tissues revealed YAP1 staining intensities were moderate to strong in the nucleus and cytoplasm of the tumor cells, whereas the adjacent normal epithelial showed negative to weak staining. In cultured cells, YAP1 expression and localization was modulated by cell density. YAP1 total protein expression increased in the nuclear fractions in BxPC-3 and PANC-1, while it declined in HPDE6 as cell density increased. Additionally, treatment of pancreatic cancer cell lines, BxPC-3 and PANC-1, with YAP1-targeting siRNA oligonucleotides significantly reduced their proliferation in vitro. Furthermore, treatment with YAP1 siRNA oligonucleotides diminished the anchorage-independent growth on soft agar of pancreatic cancer cells, suggesting a role of YAP1 in pancreatic cancer tumorigenesis.

CONCLUSIONS

YAP1 is overexpressed in pancreatic cancer tissues and potentially plays an important role in the clonogenicity and growth of pancreatic cancer cells.

摘要

背景

Hippo 通路通过在其激活时抑制细胞增殖和促进细胞凋亡来调节器官大小。Yes 相关蛋白 1(YAP1)是 Hippo 通路的核效应物,作为转录共激活因子促进细胞生长。在人类癌症中,YAP1 基因在几种肿瘤类型中被报道扩增和过度表达。

方法

使用 YAP1 蛋白的免疫组织化学染色来评估胰腺肿瘤组织中 YAP1 的表达。使用 siRNA 寡核苷酸敲低 YAP1 的表达,并使用细胞增殖、凋亡和非锚定依赖性生长测定来研究其对胰腺癌细胞的影响。Wilcoxon 符号秩检验、Pearson 相关系数、Kendall's Tau、Spearman's Rho 和独立的两样本 t(双侧)检验用于确定数据的统计学意义。

结果

在胰腺肿瘤组织的免疫组织化学研究中,YAP1 染色强度在肿瘤细胞的核和细胞质中为中度至强,而相邻的正常上皮呈阴性至弱染色。在培养的细胞中,YAP1 的表达和定位受细胞密度的调节。在 BxPC-3 和 PANC-1 中,YAP1 总蛋白表达在核部分增加,而随着细胞密度的增加,HPDE6 中的表达下降。此外,用 YAP1 靶向 siRNA 寡核苷酸处理胰腺癌细胞系 BxPC-3 和 PANC-1,显著减少了它们在体外的增殖。此外,YAP1 siRNA 寡核苷酸处理减少了胰腺癌细胞在软琼脂上的非锚定依赖性生长,表明 YAP1 在胰腺癌细胞肿瘤发生中起作用。

结论

YAP1 在胰腺癌细胞中过度表达,并且可能在胰腺癌细胞的集落形成和生长中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/e865e6192b2b/pone.0032783.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/07d4ffa1bf82/pone.0032783.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/e84fcd01dfb8/pone.0032783.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/94a1c13155e3/pone.0032783.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/dfb40ed6c934/pone.0032783.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/e865e6192b2b/pone.0032783.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/07d4ffa1bf82/pone.0032783.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/e84fcd01dfb8/pone.0032783.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/94a1c13155e3/pone.0032783.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/dfb40ed6c934/pone.0032783.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4761/3291657/e865e6192b2b/pone.0032783.g005.jpg

相似文献

1
Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.下调 Yes 相关蛋白 1 的表达可降低胰腺癌细胞的增殖和克隆形成能力。
PLoS One. 2012;7(3):e32783. doi: 10.1371/journal.pone.0032783. Epub 2012 Mar 1.
2
[Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].[双皮质素样激酶1激活Hippo信号通路以促进胰腺癌细胞的迁移、侵袭和增殖]
Zhonghua Zhong Liu Za Zhi. 2023 Jul 23;45(7):594-604. doi: 10.3760/cma.j.cn112152-20221222-00845.
3
Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.Yes 相关蛋白 1 在脑膜瘤中被激活并发挥癌基因作用。
Mol Cancer Res. 2012 Jul;10(7):904-13. doi: 10.1158/1541-7786.MCR-12-0116. Epub 2012 May 22.
4
Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway.Yes 相关蛋白 1(YAP1)通过激活 AXL/MAPK 通路促进人胆囊肿瘤生长。
Cancer Lett. 2014 Dec 28;355(2):201-9. doi: 10.1016/j.canlet.2014.08.036. Epub 2014 Sep 10.
5
Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis.Yes相关蛋白1过表达是胰腺导管腺癌患者的独立预后标志物,与肝转移和预后不良相关。
Pancreas. 2017 Aug;46(7):913-920. doi: 10.1097/MPA.0000000000000867.
6
COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.COPB2 通过上调肺腺癌细胞中 YAP1 的表达促进细胞增殖和肿瘤发生。
Biomed Pharmacother. 2018 Jul;103:373-380. doi: 10.1016/j.biopha.2018.04.006. Epub 2018 Apr 24.
7
YAP1 Is Involved in Tumorigenic Properties of Prostate Cancer Cells.YAP1参与前列腺癌细胞的致瘤特性。
Pathol Oncol Res. 2020 Apr;26(2):867-876. doi: 10.1007/s12253-019-00634-z. Epub 2019 Mar 11.
8
RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.RASAL2 通过 hippo 信号通路的 LATS2/YAP1 轴促进结直肠癌的肿瘤进展。
Mol Cancer. 2018 Jul 23;17(1):102. doi: 10.1186/s12943-018-0853-6.
9
miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.miR-375 通过靶向 Hippo 通路中的 YAP1/TEAD4-CTGF 轴参与胃癌发生。
Cell Death Dis. 2018 Jan 24;9(2):92. doi: 10.1038/s41419-017-0134-0.
10
Angiomotin-like proteins associate with and negatively regulate YAP1.血管生成素样蛋白与 YAP1 结合并负调控其活性。
J Biol Chem. 2011 Feb 11;286(6):4364-70. doi: 10.1074/jbc.C110.205401. Epub 2010 Dec 27.

引用本文的文献

1
BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis.BUB1通过抑制铁死亡促进胰腺癌细胞对吉西他滨的耐药性。
Cancers (Basel). 2024 Apr 18;16(8):1540. doi: 10.3390/cancers16081540.
2
Effects of RNA methylation on Tumor angiogenesis and cancer progression.RNA 甲基化对肿瘤血管生成和癌症进展的影响。
Mol Cancer. 2023 Dec 6;22(1):198. doi: 10.1186/s12943-023-01879-8.
3
Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer Cells.

本文引用的文献

1
A screen for conditional growth suppressor genes identifies the Drosophila homolog of HD-PTP as a regulator of the oncoprotein Yorkie.一种条件生长抑制基因的筛选方法鉴定出果蝇同源物 HD-PTP 作为致癌蛋白 Yorkie 的调节剂。
Dev Cell. 2011 May 17;20(5):700-12. doi: 10.1016/j.devcel.2011.04.012.
2
Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells.厄洛替尼与 MEK 抑制剂在 KRAS 野生型人胰腺癌细胞中的协同作用。
Clin Cancer Res. 2011 May 1;17(9):2744-56. doi: 10.1158/1078-0432.CCR-10-2214. Epub 2011 Mar 8.
3
Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
YAP/TAZ-TEAD 转录复合物在癌细胞中通过甲羟戊酸途径对 TRAIL 敏感性的代谢控制中的作用。
Cells. 2023 Sep 27;12(19):2370. doi: 10.3390/cells12192370.
4
Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target.Yes相关蛋白-1在眼表鳞状上皮肿瘤中的过表达;一种潜在的诊断标志物和治疗靶点。
Front Oncol. 2023 Jul 5;13:1213426. doi: 10.3389/fonc.2023.1213426. eCollection 2023.
5
Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside.靶向胃癌及其他消化系统恶性肿瘤中的河马通路:从 bench 到 bedside
Biomedicines. 2022 Oct 8;10(10):2512. doi: 10.3390/biomedicines10102512.
6
Establishment of a pancreatic cancer animal model using the pancreas-targeted hydrodynamic gene delivery method.利用胰腺靶向性流体动力学基因递送方法建立胰腺癌动物模型。
Mol Ther Nucleic Acids. 2022 Mar 28;28:342-352. doi: 10.1016/j.omtn.2022.03.019. eCollection 2022 Jun 14.
7
Mechanical Cues, E-Cadherin Expression and Cell "Sociality" Are Crucial Crossroads in Determining Pancreatic Ductal Adenocarcinoma Cells Behavior.机械线索、E-钙黏蛋白表达和细胞“社会性”是决定胰腺导管腺癌细胞行为的关键转折点。
Cells. 2022 Apr 13;11(8):1318. doi: 10.3390/cells11081318.
8
Novel insights into the mechanisms by which lncRNA HOTAIR regulates migration and invasion in HeLa cells.长链非编码 RNA HOTAIR 调控 HeLa 细胞迁移和侵袭的作用机制的新见解。
Cell Cycle. 2022 Mar-Mar;21(6):602-617. doi: 10.1080/15384101.2022.2030167. Epub 2022 Jan 28.
9
Hippo Pathway in Regulating Drug Resistance of Glioblastoma.Hippo 通路在调控脑胶质母细胞瘤耐药中的作用。
Int J Mol Sci. 2021 Dec 14;22(24):13431. doi: 10.3390/ijms222413431.
10
Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma.YAP/TAZ在胰腺导管腺癌中的生物学意义
Front Oncol. 2021 Jul 29;11:700315. doi: 10.3389/fonc.2021.700315. eCollection 2021.
Yes 相关蛋白 1 在胃癌中表现出致癌特性,其核积累与预后不良相关。
Clin Cancer Res. 2011 Apr 15;17(8):2130-9. doi: 10.1158/1078-0432.CCR-10-2467. Epub 2011 Feb 23.
4
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene.Hippo 通路转录共激活因子 YAP 是一种卵巢癌致癌基因。
Oncogene. 2011 Jun 23;30(25):2810-22. doi: 10.1038/onc.2011.8. Epub 2011 Feb 14.
5
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.血管生成素是 Hippo 通路的一个新组成部分,可抑制 YAP 癌蛋白。
Genes Dev. 2011 Jan 1;25(1):51-63. doi: 10.1101/gad.2000111.
6
YAP is a candidate oncogene for esophageal squamous cell carcinoma.YAP 是食管鳞状细胞癌的候选癌基因。
Carcinogenesis. 2011 Mar;32(3):389-98. doi: 10.1093/carcin/bgq254. Epub 2010 Nov 26.
7
The hippo signaling pathway in development and cancer.河马信号通路在发育和癌症中的作用。
Dev Cell. 2010 Oct 19;19(4):491-505. doi: 10.1016/j.devcel.2010.09.011.
8
Targeting YAP and Hippo signaling pathway in liver cancer.肝癌中 YAP 和 Hippo 信号通路的靶向治疗。
Expert Opin Ther Targets. 2010 Aug;14(8):855-68. doi: 10.1517/14728222.2010.499361.
9
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.Hippo-YAP 通路在器官大小控制和肿瘤发生中的作用:更新版本。
Genes Dev. 2010 May;24(9):862-74. doi: 10.1101/gad.1909210.
10
MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties.微小 RNA-375 靶向肝癌中的 Hippo 信号效应物 YAP 并抑制肿瘤特性。
Biochem Biophys Res Commun. 2010 Apr 9;394(3):623-7. doi: 10.1016/j.bbrc.2010.03.036. Epub 2010 Mar 10.